Simons Foundation | Genomics of ASD: Pathways to Biological Convergence and Genetic Therapies
Event details
Date | 18.08.2022 |
Category | Call for proposal |
Aim: The mission of the Simons Foundation Autism Research Initiative (SFARI) is to improve the understanding, diagnosis and treatment of autism spectrum disorders (ASD) by funding innovative research of the highest quality and relevance.
Grants awarded through this request for applications (RFA) are intended to advance our understanding of the genetic basis of ASD and the molecular and cellular consequences of genetic risk, and to provide a foundation for the development of treatments for select genetically defined forms of the condition. SFARI seeks proposals in three different areas, with the common goal of identifying new possibilities for intervention:
To enhance support of projects all along the continuum of translation, SFARI now offers three tracks within this RFA solicitation:
Duration: Explorer track – 24 months
Expansion track – 36 months
Collaboration track – 36 months
Funding: Explorer track – $400,000
Expansion track – $1,500,000
Collaboration track - $750,000
Eligibility: All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, and units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.
How to Apply: All interested grant applicants must submit their applications online through proposalCENTRAL. To begin, log in as an applicant, navigate to the grant opportunities tab, select Simons Foundation from the ’Filter by Grant Maker’ drop-down list. You will then see the list of current Simons Foundation grant opportunities and will be able to select ‘Genomics: Pathways to Biological Convergence and Genetic Therapies’.
If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. A signature page and tax status information are required for this submission; contact the Research Office for guidance as early as possible.
Deadline: 18 August 2022
Further information
Grants awarded through this request for applications (RFA) are intended to advance our understanding of the genetic basis of ASD and the molecular and cellular consequences of genetic risk, and to provide a foundation for the development of treatments for select genetically defined forms of the condition. SFARI seeks proposals in three different areas, with the common goal of identifying new possibilities for intervention:
- Integrative Analyses of Multi-omic ASD Data
- Functional Analysis of Associated Variants
- Genetic Therapies
To enhance support of projects all along the continuum of translation, SFARI now offers three tracks within this RFA solicitation:
- The Explorer track is appropriate for early-stage projects where establishing feasibility and proof-of-concept are the most relevant outcomes of the grant period.
- The Expansion track is appropriate for more mature projects with evidence of feasibility and preliminary validity.
- The Collaboration track is appropriate for multi-lab collaborative projects.
Duration: Explorer track – 24 months
Expansion track – 36 months
Collaboration track – 36 months
Funding: Explorer track – $400,000
Expansion track – $1,500,000
Collaboration track - $750,000
Eligibility: All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, and units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.
How to Apply: All interested grant applicants must submit their applications online through proposalCENTRAL. To begin, log in as an applicant, navigate to the grant opportunities tab, select Simons Foundation from the ’Filter by Grant Maker’ drop-down list. You will then see the list of current Simons Foundation grant opportunities and will be able to select ‘Genomics: Pathways to Biological Convergence and Genetic Therapies’.
If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. A signature page and tax status information are required for this submission; contact the Research Office for guidance as early as possible.
Deadline: 18 August 2022
Further information
- More information about the program is available here.
- The application portal proposalCENTRAL can be found here.
- For any other questions, or to complete the signature page, please contact the Research Office.
Practical information
- General public
- Free